UBS Group AG - HELIUS MED TECHNOLOGIES INC ownership

HELIUS MED TECHNOLOGIES INC's ticker is HSDTXXXX and the CUSIP is 42328V504. A total of 30 filers reported holding HELIUS MED TECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HELIUS MED TECHNOLOGIES INC
ValueSharesWeighting
Q4 2020$0
-100.0%
180
-99.3%
0.00%
Q3 2020$10,00025,417
+14020.6%
0.00%
Q2 2020$0
-100.0%
180
-93.8%
0.00%
Q1 2020$1,000
-94.7%
2,887
-85.5%
0.00%
Q4 2019$19,000
+1800.0%
19,850
+2925.9%
0.00%
Q3 2019$1,000
-95.7%
656
-93.7%
0.00%
Q2 2019$23,000
-43.9%
10,397
+69.6%
0.00%
Q1 2019$41,000
-66.9%
6,130
-55.0%
0.00%
Q4 2018$124,000
+210.0%
13,635
+234.4%
0.00%
Q3 2018$40,000
+100.0%
4,078
+96.1%
0.00%
Q2 2018$20,0002,0800.00%
Other shareholders
HELIUS MED TECHNOLOGIES INC shareholders Q3 2020
NameSharesValueWeighting ↓
Rovida Advisors Inc. 1,292,690$1,254,0000.07%
ISTHMUS PARTNERS, LLC 204,829$199,0000.04%
Virtu Financial LLC 85,388$83,0000.01%
Good Life Advisors, LLC 10,811$10,0000.00%
UBS Group AG 19,850$19,0000.00%
Sowell Financial Services LLC 1$00.00%
IFP Advisors, Inc 0$00.00%
BNP PARIBAS FINANCIAL MARKETS 15$15,0000.00%
Advisor Group, Inc. 20$00.00%
US BANCORP \DE\ 500$00.00%
View complete list of HELIUS MED TECHNOLOGIES INC shareholders